Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12616688 | Cell glycocalyx protection effect of anisodamine | 🖼🧊📄§ | 2026-05-05 | 2041-09-01 | 0 | 31 |
| 12616654 | Stainless steel can for pressurised metered dose inhalers | 🖼🧊📄§ | 2026-05-05 | 2039-12-02 | 0 | 31 |
| 12617752 | Rapidly metabolized lipid compound | 🖼🧊📄§ | 2026-05-05 | 2044-06-06 | 0 | 31 |
| 12616699 | Ophthalmic formulations of methotrexate | 🖼🧊📄§ | 2026-05-05 | 2040-09-11 | 0 | 31 |
| 12616695 | Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases | 🖼🧊📄§ | 2026-05-05 | 2041-01-29 | 0 | 31 |
| 12616717 | Regenerative CO2 treatment apparatus and method | 🖼🧊📄§ | 2026-05-05 | 2040-07-09 | 0 | 31 |
| 12616730 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-03-10 | 0 | 31 |
| 12616602 | Bacteria formulation and products including same | 🖼🧊📄§ | 2026-05-05 | 2041-08-04 | 0 | 31 |
| 12616750 | Combination therapy utilizing DNA alkylating agents and ATR inhibitors | 🖼🧊📄§ | 2026-05-05 | 2039-10-14 | 0 | 31 |
| 12616702 | Use of reboxetine to treat narcolepsy | 🖼🧊📄§ | 2026-05-05 | 2044-08-29 | 0 | 31 |
| 12616673 | Compounds for use in the treatment of leukemia | 🖼🧊📄§ | 2026-05-05 | 2041-01-28 | 0 | 31 |
| 12616713 | Methods for enhancing vascular density | 🖼🧊📄§ | 2026-05-05 | 2043-01-20 | 0 | 31 |
| 12616703 | Methods of contraception using nomegestrol acetate and estradiol | 🖼🧊📄§ | 2026-05-05 | 2041-10-12 | 0 | 31 |
| 12616674 | Anti-fibrotic NEU3 inhibitor compounds and methods of use | 🖼🧊📄§ | 2026-05-05 | 2040-02-10 | 0 | 31 |
| 12616716 | Wound healing dressings and formulations and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2044-12-11 | 0 | 31 |
| 12616667 | Compositions and methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-05-05 | 2042-11-14 | 0 | 31 |
| 12617766 | Crystal form of thiophene derivative and preparation method therefor | 🖼🧊📄§ | 2026-05-05 | 2042-04-21 | 0 | 31 |
| 12617782 | Pyridazinones as PARP7 inhibitors | 🖼🧊📄§ | 2026-05-05 | 2043-05-12 | 0 | 31 |
| 12616670 | N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections | 🖼🧊📄§ | 2026-05-05 | 2041-03-23 | 0 | 31 |
| 12617801 | Tetrahydrothieno pyridine derivatives as DDRS inhibitors | 🖼🧊📄§ | 2026-05-05 | 2042-03-25 | 0 | 31 |
| 12617765 | Cannabinoid derivatives | 🖼🧊📄§ | 2026-05-05 | 2040-11-27 | 0 | 31 |
| 12617830 | Analogues of PYY | 🖼🧊📄§ | 2026-05-05 | 2043-11-30 | 0 | 31 |
| 12618070 | Increasing Atoh1 life to drive sensorineural hair cell differentiation | 🖼🧊📄§ | 2026-05-05 | 2042-03-04 | 0 | 31 |
| 12617783 | Heterocyclic GLP-1R agonists | 🖼🧊📄§ | 2026-05-05 | 2045-03-28 | 0 | 31 |
| 12618059 | Anc80 encoding sphingolipid-metabolizing proteins | 🖼🧊📄§ | 2026-05-05 | 2039-03-07 | 0 | 31 |
| 12617825 | Methods and compositions for reducing the immunogenicity of chimeric notch receptors | 🖼🧊📄§ | 2026-05-05 | 2042-04-08 | 0 | 31 |
| 12618024 | Microcell systems for controlled release of fragrances | 🖼🧊📄§ | 2026-05-05 | 2042-12-20 | 0 | 31 |
| 12618044 | Specification of functional cranial placode derivatives from human pluripotent stem cells | 🖼🧊📄§ | 2026-05-05 | 2042-12-21 | 0 | 31 |
| 12617858 | Anti-Müllerian hormone receptor 2 antibodies and methods of use | 🖼🧊📄§ | 2026-05-05 | 2041-01-29 | 0 | 31 |
| 12616646 | Use of rochelle salt | 🖼🧊📄§ | 2026-05-05 | 2041-12-15 | 0 | 31 |
| 12616665 | Neutrophil-to-lymphocyte ratio decreasing agent | 🖼🧊📄§ | 2026-05-05 | 2041-11-12 | 0 | 31 |
| 12617861 | Anti-OX40 antibody and method of treatment | 🖼🧊📄§ | 2026-05-05 | 2041-04-16 | 0 | 31 |
| 12616662 | Lipid particles for nucleic acid delivery and clinical applications of same | 🖼🧊📄§ | 2026-05-05 | 2042-11-17 | 0 | 31 |
| 12617809 | Cardioprotective lipid and method of use | 🖼🧊📄§ | 2026-05-05 | 2042-09-22 | 0 | 31 |
| 12617014 | AU, AG and rich phytochemical payload nanomaterials, antiviral/antibacterial products and synthesis methods | 🖼🧊📄§ | 2026-05-05 | 2042-05-10 | 0 | 31 |
| 12616656 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | 🖼🧊📄§ | 2026-05-05 | 2042-05-20 | 0 | 31 |
| 12616734 | Chimeric antigen receptor specifically binding to cd 300C antigen or receptor thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-27 | 0 | 31 |
| 12616723 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | 🖼🧊📄§ | 2026-05-05 | 2043-11-13 | 0 | 31 |
| 12618065 | MiRNA detargeting system for tissue specific interference | 🖼🧊📄§ | 2026-05-05 | 2038-10-02 | 0 | 31 |
| 12618066 | Promoter having high activity in activated T-cell | 🖼🧊📄§ | 2026-05-05 | 2040-11-13 | 0 | 31 |
| 12618076 | Methods of engineering platelets for targeting circulating tumor cells | 🖼🧊📄§ | 2026-05-05 | 2040-09-30 | 0 | 31 |
| 12618082 | Engineered muscle targeting compositions | 🖼🧊📄§ | 2026-05-05 | 2042-03-29 | 0 | 31 |
| 12617762 | Carboxy derivatives with antiinflamatory properties | 🖼🧊📄§ | 2026-05-05 | 2040-12-23 | 0 | 31 |
| 12617790 | Mitragynine analogs and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12617805 | Codrug that disintegrates in intestine, preparation therefor, and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-19 | 0 | 31 |
| 12617811 | HPK1 inhibitors and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-02 | 0 | 31 |
| 12617812 | Platinum(IV) complexes, methods of manufacture, compositions containing, and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-25 | 0 | 31 |
| 12617807 | Long lasting opioid reversal using hydrogen peroxide-induced release in blood | 🖼🧊📄§ | 2026-05-05 | 2042-04-01 | 0 | 31 |
| 12617822 | Arc-based capsids and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-10-13 | 0 | 31 |
| 12617820 | Engineered coronavirus spike (s) protein and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |